Yao Huan, Huang Ting, Li Zhifang, Wu Huaxin, Li Xueyao, Tang Hua, Su Fuhai, Jin Xinliang, Zhang Wei
National Institute of Metrology, Beijing 100029, P.R.China.
Jiangsu Hanbon Technology Co., Ltd., Jiangsu 223000, P.R.China.
Anal Chem. 2025 Jul 22;97(28):15181-15189. doi: 10.1021/acs.analchem.5c01664. Epub 2025 Jul 14.
Purity assessment is critical for the quality control of active pharmaceutical ingredients (APIs). However, there is a lack of rapid and accurate purity assessment methods that operate independently of target-specific certified reference materials (CRMs). Herein, we proposed a traceable quantification method, named SFC-ISC-qNMR, for purity assessment and quantitative determination of low-purity APIs, which was accomplished by tracing the test solution to the reference solution via supercritical fluid chromatography (SFC) collection with internal standard-correction (ISC), followed by an SI-traceable quantitative nuclear magnetic resonance (qNMR) analysis of the reference solution (SI = International System of Units). Digitoxin, a widely used cardiac glycoside in the treatment of heart failure and arrhythmias, was used as a model compound. By employing a mobile phase of supercritical CO modified with 24%-26% methanol, digitoxin with a purity exceeding 99.87% was isolated and collected. A national CRM of ethyl -hydroxybenzoate was used as the IS for digitoxin. The SFC-ISC reference solution can be prepared in 15 min without the need for precise weighing, simply by reconstitution of the SFC collected high-purity analyte in deuterated methanol containing IS. The feasibility and reliability of the SFC-ISC-qNMR method were exhibited through the quantitative determination of digitoxin in chemical mixtures. The purity of a commercially available digitoxin reagent was determined to be 94.17% ± 0.15%, which was consistent with high-resolution qNMR analysis. The contents of spiked digitoxin in a digoxin analytical standard were measured at 1.06%, 1.37%, 2.39%, and 4.43%, respectively, showing high consistency with the gravimetric value with a bias less than 0.13%. In contrast, direct qNMR with deconvolution and HPLC analysis failed to provide accurate measurements. These results highlight the applicability of the SFC-ISC-qNMR method for drug evaluation and research, demonstrating its significant potential for the purity assessment of APIs.
纯度评估对于活性药物成分(API)的质量控制至关重要。然而,目前缺乏独立于目标特异性有证标准物质(CRM)的快速、准确的纯度评估方法。在此,我们提出了一种名为SFC-ISC-qNMR的可溯源定量方法,用于低纯度API的纯度评估和定量测定,该方法通过超临界流体色谱(SFC)收集并进行内标校正(ISC),将测试溶液追溯至参考溶液,随后对参考溶液进行国际单位制(SI)可溯源的定量核磁共振(qNMR)分析。洋地黄毒苷是一种广泛用于治疗心力衰竭和心律失常的强心苷,用作模型化合物。通过使用24%-26%甲醇改性的超临界CO流动相,分离并收集了纯度超过99.87%的洋地黄毒苷。使用国家有证标准物质对羟基苯甲酸乙酯作为洋地黄毒苷的内标。SFC-ISC参考溶液可在15分钟内制备完成,无需精确称重,只需将SFC收集的高纯度分析物在含有内标的氘代甲醇中复溶即可。通过对化学混合物中洋地黄毒苷的定量测定,展示了SFC-ISC-qNMR方法的可行性和可靠性。市售洋地黄毒苷试剂的纯度测定为94.17%±0.15%,与高分辨率qNMR分析结果一致。地高辛分析标准品中加标洋地黄毒苷的含量分别测定为1.06%、1.37%、2.39%和4.43%,与重量法测定值高度一致,偏差小于0.13%。相比之下,直接去卷积qNMR和HPLC分析未能提供准确的测量结果。这些结果突出了SFC-ISC-qNMR方法在药物评价和研究中的适用性,证明了其在API纯度评估方面的巨大潜力。